LARC |
Half of women due for removal would continue to use their method beyond the labeled duration. For the remaining, half of replacement use would still be LARC, with the rest distributed across injectables and other self-care methods.
|
Nearly all women due for removal would continue to use their method beyond the labeled duration. For the rest, replacement use would mostly consist of self-care methods.
|
Injectable (not self-administered) |
Half of women would continue to access their reinjections, with some women shifting to self-injection. Remaining users would switch to other self-care methods.
|
Only a small share of women would continue to access reinjections, with some women switching to self-injection. Remaining users would switch to other self-care methods.
|
Pill |
|
|
Condom |
|
|